You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you to the website of our US operations, Oncopeptides Inc. at www.oncopeptides-us.com
December 6, 2020
Oncopeptides presented new data from phase 2 ANCHOR combination study in multiple myeloma the 62<sup>nd</sup> American Society of Hematology virtual annual meeting ASH, December 6, 2020. See presentation below.